Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

News Archive

COVID-19 antibodies can last up to 500 days after infection

Photo of woman getting her blood drawn. (Photo by Getty Images)

May 31, 2022

Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.

The findings were published in The Journal of Infectious Diseases.

Retired pharmacist with Huntington’s disease participates in clinical trials at UTHealth Houston

Wanting to advance science, Jon Huffman, who was diagnosed with Huntington's disease in 2014, has enrolled in multiple studies led by Erin Furr Stimming, MD, with UTHealth Houston. (Photo courtesy of Patricia Huffman)

May 26, 2022

Three generations of Jon Huffman’s family have suffered Huntington’s disease – a rare, inherited, ultimately fatal disease that causes the progressive breakdown of nerve cells in the brain and is best known for the associated involuntary movements, as well as cognitive and psychiatric symptoms. So it didn’t come as a particular surprise to Jon or Patricia Huffman, his wife of 36 years, when Jon began showing symptoms of the neurodegenerative disorder around 2007.

Page 22 of 64

Search UTHealth News

Use the form below to perform a new search.